Journal
NEURO-ONCOLOGY
Volume 15, Issue 1, Pages 83-90Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/neuonc/nos281
Keywords
CDK6; D425; medulloblastoma; microRNA; miR-124
Categories
Funding
- Pediatric Brain Tumor Foundation Institute
- Department of Neurological Surgery at the University of California, San Francisco
Ask authors/readers for more resources
Medulloblastoma is the most common malignant brain tumor in children, and a substantial number of patients die as a result of tumor progression. Overexpression of CDK6 is present in approximately one-third of medulloblastomas and is an independent poor prognostic marker for this disease. MicroRNA (miR)-124 inhibits expression of CDK6 and prevents proliferation of glioblastoma and medulloblastoma cells in vitro. We examined the effects of miR-124 overexpression on medulloblastoma cells both in vitro and in vivo and compared cell lines that have low and high CDK6 expression. MiR-124 overexpression inhibits the proliferation of medulloblastoma cells, and this effect is mediated mostly through the action of miR-124 upon CDK6. We further show that induced expression of miR-124 potently inhibits growth of medulloblastoma xenograft tumors in rodents. Further testing of miR-124 will help define the ultimate therapeutic potential of preclinical models of medulloblastoma in conjunction with various delivery strategies for treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available